Navigation Links
PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
Date:9/9/2009

PRINCETON, N.J., Sept. 9 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that it has completely paid down its Convertible Senior Notes that were due 2024 and obtained a credit line that can be used for general corporate purposes.

"The combination of our financial restructuring, business process improvements and solid operating performance has resulted in a healthy backlog of new business and renewed optimism," commented Jeffrey P. McMullen, president and chief executive officer. "With our financial challenges behind us, clients can be assured PharmaNet Development Group is in a strong position for long term growth."

In addition, the Company has continued to expand its global reach in the Asia Pacific region. The recently opened office in Manila, Philippines further enhances PharmaNet Development Group's presence in the region consisting of two offices in India, two offices in China, offices in South Korea, Singapore and Taiwan, and field based staff in Australia, Malaysia and Thailand. The Company is planning an expansion of its Singapore office in 2010 and continues to invest in personnel and other strategic assets.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at '/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
2. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
3. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
4. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
5. PharmaNet Development Group Agrees to be Acquired by JLL Partners
6. China Biologic Products Appoints Director of Research and Development
7. Multiple Abstracts Related to KRYSTEXXA(TM) Development and Treatment Failure Gout to be Presented at the 2009 ACR/ARHP Annual Scientific Meeting
8. Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation ff the Ipsens Proprietary CDC25[1] Inhibitor (IRC-083864 or Debio 0931), an Anti-Cancer Agent
9. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
10. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
11. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... LONDON , May 1, 2015 ... world market for antithrombotic drugs will reach $22.4bn in ... Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 ... purpose of that investigation is to provide forecasts and ... a business information publisher and consultancy in ...
(Date:5/1/2015)... , May 1, 2015 Albany Molecular ... William S. Marth , AMRI,s President and Chief ... Merrill Lynch 2015 Health Care Conference on Wednesday, May ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:5/1/2015)... and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Roger Jeffs , Ph.D., ... an overview and update on the company,s business at the ... Boston, Massachusetts . The presentation ... PM Eastern Time, and can be accessed via a live ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2
... 2011 Bio-Research Products announced today that it is adding ... its product line. The new Glutathione Reductase offers customers a ... liquid (#801) GR enzyme. Both versions are free of ammonium ... IU/mg protein and an enzyme activity of 300 IU/mL. ...
... Inc. (OTCBB: UGNE), a leader in ... announced that Ashleigh Palmer, President and Chief Executive Officer, ... Annual Oppenheimer Healthcare Conference being held in New York ... 4:10 p.m. ET on Tuesday, December 13, 2011. ...
...  Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company ... for the treatment of autoimmune diseases and cancer, ... the Company,s President, Chief Executive Officer and Director, ... Conference on Wednesday, December 14, 2011 at 10:30 ...
Cached Biology Technology:Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 2Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... essential nutrient and a pollutant, a byproduct of fossil ... benefit and a hazard, depending on form, location, and ... around the planet, say sixteen scientists in the latest ... "Excess Nitrogen in the U.S. Environment: Trends, Risks, and ...
... simple experiment, University of Illinois chemists have debunked a ... by chemistry professor and Howard Hughes Medical Institute early ... top drug for treating systemic fungal infections works by ... physiology, a finding that could change the direction of ...
... sex of a fetus until after 30 weeks of pregnancy ... groups in Canada and the United States, states an editorial ... Female feticide that is, choosing to abort female ... issue in several Asian countries including India, China, Korea and ...
Cached Biology News:Solutions for a nitrogen-soaked world 2Powerful drug's surprising, simple method could lead to better treatments 2Powerful drug's surprising, simple method could lead to better treatments 3Female feticide in Canada requires action 2